Literature DB >> 25425976

Inflammation and C-reactive protein in atrial fibrillation: cause or effect?

Roberto Galea, Maria Teresa Cardillo, Annalisa Caroli, Maria Giulia Marini, Chiara Sonnino, Maria L Narducci, Luigi M Biasucci.   

Abstract

Atrial fibrillation is associated with substantial morbidity and mortality rates. The incompletely understood pathogenesis of this cardiac dysrhythmia makes it difficult to improve approaches to primary and secondary prevention. Evidence has accumulated in regard to a relationship between inflammation and atrial fibrillation. Investigators have correlated the dysrhythmia with myocarditis, pericardiotomy, and C-reactive protein levels, suggesting that inflammation causes atrial fibrillation or participates in its onset and continuation. Conversely, other investigators suggest that atrial fibrillation induces an inflammatory response. In this review, we summarize and critically discuss the nature and clinical role of inflammation and C-reactive protein in atrial fibrillation.

Entities:  

Keywords:  Atrial fibrillation/diagnosis/etiology/physiopathology/prevention & control; C-reactive protein/analysis/metabolism; biological markers/blood; disease management; heart conduction system/physiopathology; inflammation/complications/diagnosis/etiology; myocardial revascularization/adverse effects; polymorphism, genetic; primary prevention; risk factors

Mesh:

Substances:

Year:  2014        PMID: 25425976      PMCID: PMC4189345          DOI: 10.14503/THIJ-13-3466

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  66 in total

1.  Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation.

Authors:  Mónica Acevedo; Ramón Corbalán; Sandra Braun; Jaime Pereira; Ilse González; Carlos Navarrete
Journal:  J Thromb Thrombolysis       Date:  2012-02-03       Impact factor: 2.300

2.  Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis.

Authors:  Kwok M Ho; Jen Aik Tan
Journal:  Circulation       Date:  2009-03-30       Impact factor: 29.690

Review 3.  Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets.

Authors:  Joachim R Ehrlich; Stanley Nattel; Stefan H Hohnloser
Journal:  J Cardiovasc Electrophysiol       Date:  2002-04

4.  Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes.

Authors:  T Morgera; A Di Lenarda; L Dreas; B Pinamonti; F Humar; R Bussani; F Silvestri; D Chersevani; F Camerini
Journal:  Am Heart J       Date:  1992-08       Impact factor: 4.749

Review 5.  Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation.

Authors:  Lixia Yue; Jia Xie; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2010-10-20       Impact factor: 10.787

Review 6.  The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications.

Authors:  Dobromir Dobrev; Niels Voigt; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2010-10-12       Impact factor: 10.787

Review 7.  Current concepts in the pathogenesis of atrial fibrillation.

Authors:  Antonios Kourliouros; Irina Savelieva; Anatoli Kiotsekoglou; Marjan Jahangiri; John Camm
Journal:  Am Heart J       Date:  2008-12-24       Impact factor: 4.749

8.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

Review 9.  A proposal for new clinical concepts in the management of atrial fibrillation.

Authors:  A John Camm; Sana M Al-Khatib; Hugh Calkins; Jonathan L Halperin; Paulus Kirchhof; Gregory Y H Lip; Stanley Nattel; Jeremy Ruskin; Amitava Banerjee; Dan Blendea; Eduard Guasch; Matthew Needleman; Irina Savelieva; Juan Viles-Gonzalez; Eric S Williams
Journal:  Am Heart J       Date:  2012-08-03       Impact factor: 4.749

10.  Structural correlate of atrial fibrillation in human patients.

Authors:  Sawa Kostin; Gabi Klein; Zoltan Szalay; Stefan Hein; Erwin P Bauer; Jutta Schaper
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

View more
  24 in total

1.  Vaccination and risk of lone atrial fibrillation in the active component United States military.

Authors:  Michael M McNeil; Susan K Duderstadt; Jennifer F Sabatier; Gina G Ma; Jonathan Duffy
Journal:  Hum Vaccin Immunother       Date:  2019-01-08       Impact factor: 3.452

2.  Pharmacogenetics and precision medicine: Is inflammation a covert threat to effective genotype-based therapy?

Authors:  Rashmi R Shah
Journal:  Ther Adv Drug Saf       Date:  2017-06-19

Review 3.  Applications of Graphene Quantum Dots in Biomedical Sensors.

Authors:  Bhargav D Mansuriya; Zeynep Altintas
Journal:  Sensors (Basel)       Date:  2020-02-16       Impact factor: 3.576

4.  Associations of Asthma and Asthma Control With Atrial Fibrillation Risk: Results From the Nord-Trøndelag Health Study (HUNT).

Authors:  Aivaras Cepelis; Ben M Brumpton; Vegard Malmo; Lars E Laugsand; Jan Pål Loennechen; Hanne Ellekjær; Arnulf Langhammer; Imre Janszky; Linn B Strand
Journal:  JAMA Cardiol       Date:  2018-08-01       Impact factor: 14.676

5.  Atrial Fibrillation in Patients with Septic Shock: A One-Year Observational Pilot Study.

Authors:  Irene Steinberg; Etrusca Brogi; Lorenza Pratali; Danila Trunfio; Greta Giuliano; Elena Bignami; Francesco Forfori
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-01-24

6.  NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias.

Authors:  Larry Scott; Anke C Fender; Arnela Saljic; Luge Li; Xiaohui Chen; Xiaolei Wang; Dominik Linz; Jilu Lang; Mathias Hohl; Darragh Twomey; Thuy T Pham; Rodrigo Diaz-Lankenau; Mihail G Chelu; Markus Kamler; Mark L Entman; George E Taffet; Prashanthan Sanders; Dobromir Dobrev; Na Li
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

7.  Periodontal Disease, Atrial Fibrillation and Stroke.

Authors:  Souvik Sen; Kolby Redd; Tushar Trivedi; Kevin Moss; Alvaro Alonso; Elsayed Z Soliman; Jared W Magnani; Lin Y Chen; Rebecca F Gottesman; Wayne Rosamond; James Beck; Stephen Offenbacher
Journal:  Am Heart J       Date:  2021-01-24       Impact factor: 4.749

8.  Risk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study.

Authors:  Der-Yuan Chen; Ching-Heng Lin; Yi-Ming Chen; Hsin-Hua Chen
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

Review 9.  Postoperative Atrial Fibrillation Following Cardiac Surgery: From Pathogenesis to Potential Therapies.

Authors:  Yousef Rezaei; Mohammad Mehdi Peighambari; Shayan Naghshbandi; Niloufar Samiei; Alireza Alizadeh Ghavidel; Mohammad Reza Dehghani; Majid Haghjoo; Saeid Hosseini
Journal:  Am J Cardiovasc Drugs       Date:  2020-02       Impact factor: 3.571

10.  Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients.

Authors:  Qiang Tan; Shuangyue Zhang; Xiaoyi Zou; Jun Zhao; Jia Hao; Qian Sun
Journal:  Anatol J Cardiol       Date:  2017-04-10       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.